Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTatton Asset Management Regulatory News (TAM)

Share Price Information for Tatton Asset Management (TAM)

Share Price is delayed by 15 minutes
Get Live Data
586.00    -2.00 (-0.34%)
Bid:
584.00
Ask:
588.00
Spread: 4.00 (0.685%)
Market Cap: £357.54m
TAM Live PriceLast checked at - London Stock Exchange

Intraday Tatton Asset Management Share Chart

Director Appointment

2 Jul 2009 07:00

RNS Number : 9567U
Titanium Asset Management Corp
02 July 2009
 



Titanium Asset Management Corp.

('Titanium' or the 'Company')

Appointment of director

Titanium Asset Management Corp., the multiproduct asset management company, is pleased to announce the appointment of Mr. Shy Talmon as director of the Company. Mr Talmon has been appointed by Clal Finance Ltd ("Clal Finance"), Titanium's largest shareholder, pursuant to the terms of the certificate of incorporation and bylaws of the Company at the time of admission of the Company to AIM.

Mr Talmon51was recently appointed the CEO of of Clal Insurance Enterprises Holdings Ltd. From 2000 to 2008 Mr Talmon worked at Israel's biggest bank, Bank Hapoalim, where he was most recently its deputy CEO and head of its corporate banking department. From 1995 to 1999, Mr Talmon worked at the Israel Finance Ministry.

Nigel Wightman, Chairman and CEO of Titanium,said today: 'We are delighted to welcome Shy Talmon to the board of Titanium and look forward to working closely with him as we look to grow the business and capitalise on the opportunities available to us.' 

Mr Talmon is a director or has been a director of the following companies during the previous five years:

Current Directorships:

Clal Health Insurance Company Ltd

Clal Credit Company Ltd

Clal Gemel Ltd

Meitavit-Atudot Pension Funds Management Company Ltd

Clal Agency Holdings (1998) Ltd

Betah Ltd

Clal First Ltd

Clal First-Health Ltd

Toren Insurance Agencies Ltd

Tmura Insurance Agency (1987) Ltd

Clalbit Health General Insurance Agency (1999) Ltd

Ararat Holdings Ltd

Clal Credit & Finance Ltd

Clal Health Hospitalization Services Ltd

Clal Health O.R.S Hospitalization (Haifa) Ltd

Clal Health Hospitalization Services (Eyal) Ltd

Clal Financing Business Credit Ltd

Clal Insurance Company Properties Ltd

Ilite Real Estate A.P. Ltd

Ararat Property Ltd

Clalbit Systems Ltd

Canaf - Clal finance Management Ltd

Clalbit Insurance Agency Ltd

Clal Finance Insurance Agency Ltd

Clal Pension Services Ltd

Clalbo Ltd

Clal Health Solutions Insurance Agencies (1989) Ltd

Meitavit Provident Fund (2003) Ltd

Sinai Loss Adjusters Ltd

Shuma-Israeli Company for Assessments Ltd

Dental Health General Fund

Clal Income Generating Assets Ltd

NorGuard Insurance Group

AmGuard Insurance Company Ltd

WestGuard Insurance Company Ltd

EastGuard Insurance Company Ltd

Broadgate Underwriting Limited

S.C Clal Romania Asigurari Reasigurari S.A.

Directorships held within the previous five years:

Isracard Ltd

Mr Talmon holds no shares in the Company.

There are no other matters which are required to be announced with regard to these appointments under paragraph (g) of Schedule 2 of the AIM Rules.

For further information please contact:

Titanium Asset Management Corp.

Nigel Wightman, Chairman and CEO +44 20 7822 1881 or + 44 7789 277849

Seymour Pierce Ltd

Jonathan Wright +44 20 7107 8000

Penrose FinancialGay Collins/Elisha Vincent +44 20 7786 4882 or +44 7798 626282

titanium@penrose.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUUUWPMUPBGQG
Date   Source Headline
26th May 20267:00 amRNS-RNotice of Investor & Analyst Presentations
22nd May 20262:51 pmRNSHolding(s) in Company
21st May 202610:07 amRNSHolding(s) in Company
8th May 20264:47 pmRNSHolding(s) in Company
8th May 20262:19 pmRNSPDMR Dealing
7th May 202611:16 amRNSPDMR Dealing
27th Apr 20269:24 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSTrading Update and Notice of Final Results
18th Mar 20267:00 amRNSPDMR Dealing
6th Mar 20267:00 amRNSPDMR Dealing
5th Mar 20267:00 amRNSExercise of Options and TVR
13th Feb 20268:58 amRNSPDMR Dealing
2nd Feb 20264:52 pmRNSBlock Listing Update
30th Jan 20269:11 amRNSPDMR Dealing
12th Dec 202512:47 pmRNSPDMR Dealing
10th Dec 20257:00 amRNSPurchase of Shares by EBT
28th Nov 20253:22 pmRNSShare purchase by a Non-Executive Director
18th Nov 20257:00 amRNSUnaudited Interim Results
28th Oct 20257:00 amRNS-RNotice of Investor & Analyst Presentations
17th Oct 202512:41 pmRNSPDMR Dealing
15th Oct 202510:56 amRNSExercise of Options, PDMR Dealing and TVR
14th Oct 20257:00 amRNSTrading Update and Notice of Results
5th Sep 20252:25 pmRNSPDMR Dealing
4th Sep 20253:14 pmRNSHolding(s) in Company
29th Aug 202510:30 amRNSOptions Exercise, PDMR Dealing, Block Listing, TVR
13th Aug 20254:03 pmRNSExercise of Options and TVR
12th Aug 20257:01 amRNSAppointment of Joint Broker
12th Aug 20257:00 amRNSRelated Party Transaction
24th Jul 20254:15 pmRNSResult of AGM
22nd Jul 202512:17 pmRNSExercise of Options, PDMR Dealing and TVR
14th Jul 20255:20 pmRNSHolding(s) in Company
10th Jul 20254:52 pmRNSHolding(s) in Company
9th Jul 202510:59 amRNSHolding(s) in Company
26th Jun 20251:56 pmRNSExercise of Options, PDMR Dealings and TVR
23rd Jun 20252:12 pmRNSNotice of AGM
16th Jun 202511:42 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSFinal Results
13th May 20257:00 amRNS-RNotice of Investor & Analyst Presentations
15th Apr 20257:00 amRNSTrading Update and Notice of Chairman’s Retirement
28th Mar 20253:29 pmRNSDirector Appointment
14th Feb 20254:31 pmRNSPDMR Dealings
5th Feb 20254:37 pmRNSGrant of Options and PDMR Dealing
21st Jan 202510:31 amRNSExercise of Options and PDMR dealings
13th Nov 20247:00 amRNSUnaudited Interim Results
17th Oct 202411:52 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSTrading Update and Notice of Results
23rd Aug 202412:10 pmRNSBlock Listing Application
8th Aug 20244:16 pmRNSHolding(s) in Company
31st Jul 20242:53 pmRNSHolding(s) in Company
31st Jul 20247:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.